News | July 22, 2013

CenTrak's Real-Time Location System Aids Patient Experience at Florida Cancer Specialists

July 22, 2013 — Vizzia Technologies announced that its clinical workflow optimization solution was recently installed at Florida Cancer Specialists and Research Institute's (FCS) Tampa Cancer Center location. The newly constructed 35,990 square foot flagship facility offers a "one-stop" approach to patient care that includes medical oncology, advanced radiation oncology technology and radiological services for identifying and diagnosing tumors. The Vizzia solution, which leverages CenTrak's Clinical-Grade RTLS, is designed to transform the outpatient experience and help in optimizing patient flow processes. Shortening patient wait times and ensuring patient safety and satisfaction, as well as increasing the cancer center's patient treatment capacity are among the benefits of the new solution.

"Cancer treatment can be a daunting challenge for many of our patients. We are proud to have installed the latest technologies to enhance our patients' experiences at our center. Vizzia's advanced workflow solution allows us the visibility and data we need to accelerate the overall treatment process, so our patients can more quickly return to their normal routines," said Todd Schonherz, Florida Cancer Specialists' chief operating officer.

Vizzia integrated its Web-based information portal with the CenTrak Clinical-Grade Locating infrastructure. Their Vizzion Suite software automatically updates the location of patients and staff from CenTrak's RTLS and incorporates important workflow rules and alerts to ensure that patients move through the treatment process as efficiently as possible. The Clinical-Grade RTLS platform uses battery-operated Gen2IR and Virtual Wall devices to deliver unmatched room-, bed-, and bay-level accuracy. The advanced technology delivers rapid location update speeds and offers small, full-featured tags with extremely long battery life.

For more information: www.vizziatech.com.

Related Content

Sponsored Content | Videos | Artificial Intelligence | February 21, 2020
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intel
An example of the MRI scans showing long-term and short-term survival indications. #MRI

An example of the MRI scans showing long-term and short-term survival indications. Image courtesy of Case Western Reserve University

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — ...
Altamont’s zero-footprint solution, CaptureWare, allows Mach7’s Enterprise Imaging Platform (EIP) to ingest more DICOM and/or non-DICOM data from various sources in a facility
News | PACS | February 20, 2020
February 20, 2020 — Mach7 announced its partnership with Altamont
Sponsored Content | Videos | Enterprise Imaging | February 19, 2020
Bill Lacy, vice president, Medical Informatics at FUJIFILM Medic...
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
The Candelis ImageGrid Plus PACS Server is an ultra-high-performance platform that can support high volume healthcare environments of 1,000 plus modalities
News | PACS | February 12, 2020
February 12, 2020 — The Candelis ImageGrid Plus...
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...